Research & Evidence

Expanding Contraceptive Method Choice With a Hormonal Intrauterine Device: Results From Mixed Methods Studies in Kenya and Zambia

Few women in low- and middle-income countries have access to the hormonal intrauterine device (IUD). Past research from a small number of facilities and the private sector suggests the hormonal IUD could be an important addition to the contraceptive method mix because it is the only long-acting method some women will adopt and users report high satisfaction and continuation. This article, published in Global Health: Science and Practice, and developed by staff from MOMENTUM Country and Global Leadership, aims to determine whether these promising results were applicable in public facilities in Kenya and Zambia.

This article concludes that expanding hormonal IUD access through the public sector shows promise to increase contraceptive use and continuation in low- and middle-income countries. Efforts to strengthen availability should consider demand and engage directly with various communities, including youth, around the availability of a new long-acting option.

Note: Since this research was published, the World Health Organization has clarified that the nomenclature for “hormonal IUS” (intrauterine system) should be updated to “hormonal IUD” (intrauterine device). This article has been updated to exclude the use of “IUS,” and MOMENTUM has begun using “hormonal IUD” to refer to the category of IUDs that release the hormone levonorgestrel.

Download Article from Global Health: Science and Practice


Your privacy and security are very important to us. Please be aware that MOMENTUM Knowledge Accelerator does not collect personal information when you visit our website, unless you choose to provide that information. However, we do collect some technical information about your visit. Read our Privacy Policy.